These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34935257)

  • 21. Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).
    Myklebust-Hansen T; Aamodt G; Haugen M; Brantsæter AL; Vatn MH; Bengtson MB
    Inflamm Bowel Dis; 2017 Dec; 24(1):12-24. PubMed ID: 29272477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel.
    Dotan I; Alper A; Rachmilewitz D; Israeli E; Odes S; Chermesh I; Naftali T; Fraser G; Shitrit AB; Peles V; Reif S
    J Crohns Colitis; 2013 Aug; 7(7):542-50. PubMed ID: 23036507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018.
    Meyer A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2020 Nov; 52(9):1480-1490. PubMed ID: 33095502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
    Bröms G; Granath F; Stephansson O; Kieler H
    Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis.
    Nielsen OH; Gubatan JM; Juhl CB; Streett SE; Maxwell C
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):74-87.e3. PubMed ID: 32931960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
    Boyd HA; Basit S; Harpsøe MC; Wohlfahrt J; Jess T
    PLoS One; 2015; 10(6):e0129567. PubMed ID: 26083614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
    Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England.
    Abdul Sultan A; West J; Ban L; Humes D; Tata LJ; Fleming KM; Nelson-Piercy C; Card T
    Inflamm Bowel Dis; 2016 Jul; 22(7):1621-30. PubMed ID: 27306070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal Inflammatory Bowel Disease During Pregnancy and Infectious Disease in Offspring Younger Than 5 Years: A Population-Based Cohort Study.
    Ren T; Yu Y; Wang H; Li F; Zhang J; Li J
    Am J Gastroenterol; 2023 Mar; 118(3):491-500. PubMed ID: 36695745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD.
    Vestergaard T; Røsok J; Julsgaard M; Bek Helmig R; Friedman S; Kelsen J
    Inflamm Bowel Dis; 2024 Feb; 30(2):222-229. PubMed ID: 37075485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between maternal inflammatory bowel disease and adverse perinatal outcomes.
    Getahun D; Fassett MJ; Longstreth GF; Koebnick C; Langer-Gould AM; Strickland D; Jacobsen SJ
    J Perinatol; 2014 Jun; 34(6):435-40. PubMed ID: 24651735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis.
    Barenbrug L; Groen MT; Hoentjen F; van Drongelen J; Reek JMPAVD; Joosten I; de Jong EMGJ; van der Molen RG
    J Autoimmun; 2021 Aug; 122():102676. PubMed ID: 34126302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
    Crouwel F; Simsek M; de Boer MA; Mulder CJJ; van Andel EM; Creemers RH; van Asseldonk DP; van Bodegraven AA; Horjus CS; Visschedijk MC; Weusthuis ALM; Seinen ML; Jharap B; van Schaik FDM; Ahmad I; Boekema PJ; Tack GJ; Wormmeester L; Lutgens MWMD; van Boeckel PGA; Gilissen LPL; Kerkhof M; Russel MGVM; Hoentjen F; Bartelink ME; Kuijvenhoven JP; Maljaars JWJ; van Dop WA; Wonders J; van der Voorn MMPJA; Buiter HJC; de Boer NK
    J Crohns Colitis; 2023 May; 17(5):738-745. PubMed ID: 36521000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
    Mahadevan U; Long MD; Kane SV; Roy A; Dubinsky MC; Sands BE; Cohen RD; Chambers CD; Sandborn WJ;
    Gastroenterology; 2021 Mar; 160(4):1131-1139. PubMed ID: 33227283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study.
    Bengtson MB; Aamodt G; Mahadevan U; Vatn MH
    Inflamm Bowel Dis; 2017 Jul; 23(7):1225-1233. PubMed ID: 28452861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis.
    Zhang Y; Li D; Guo H; Wang W; Li X; Shen S
    Curr Pharm Des; 2021; 27(19):2317-2324. PubMed ID: 32938343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
    Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
    Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
    Nielsen OH; Gubatan JM; Kolho KL; Streett SE; Maxwell C
    Lancet; 2024 Mar; 403(10433):1291-1303. PubMed ID: 38458222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to Infliximab During Pregnancy: Post-Marketing Experience.
    Geldhof A; Slater J; Clark M; Chandran U; Coppola D
    Drug Saf; 2020 Feb; 43(2):147-161. PubMed ID: 31677004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.